Is telehealth allowed to prescribe Wegovy in New York?

The rise of GLP-1 medications like Wegovy, Ozempic, and Mounjaro has transformed weight management—and telehealth has made these treatments more accessible than ever. But with evolving regulations and state-by-state differences, many people wonder: Can I legally get these medications through a virtual visit?

The short answer is yes—in most cases. Since GLP-1 weight loss medications are not controlled substances, federal law doesn’t require an in-person exam before prescribing them via telehealth. However, the details vary by state, provider qualifications, and your individual health needs.

This guide breaks down everything you need to know about accessing weight loss medications through telehealth in 2025, including legal requirements, state differences, safety considerations, and what to expect from a virtual weight loss consultation.

Understanding the Federal Landscape: What’s Legal Nationwide

GLP-1 Medications Are Not Controlled Substances

Unlike stimulant medications such as Adderall or phentermine, GLP-1 agonists (semaglutide and tirzepatide) are unscheduled medications. This distinction is crucial because:

• The Ryan Haight Act, which restricts telehealth prescribing of controlled substances, does not apply to weight loss medications like Wegovy, Ozempic, or Mounjaro
• No federal law requires an in-person physical exam before a provider can prescribe these medications via telehealth
• Providers can establish a valid patient-doctor relationship through live video consultation in most states

Current Federal Telehealth Flexibilities

During the COVID-19 pandemic, the DEA waived in-person requirements for all prescriptions, including controlled substances. As of December 2025, these flexibilities have been extended through December 31, 2025 for controlled medications—though this doesn’t directly affect GLP-1 drugs, which were never restricted.

What this means for you: The federal government has signaled strong support for telehealth prescribing, and there’s widespread expectation that flexible policies will continue into 2026, either through another extension or new permanent regulations.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Variations: Where the Rules Differ

While federal law permits telehealth prescribing of weight loss medications, state regulations add another layer of requirements. Some states impose specific conditions for weight management treatment, particularly around initial evaluations and follow-up care.

States Requiring Initial In-Person Visits

Several states mandate an in-person physical examination before or shortly after starting weight loss medication via telehealth:

Strict In-Person Requirements:

• Arkansas: One of the most restrictive telehealth states; requires initial in-person encounter to establish care
• Delaware: Initial physical exam must be completed in person before telehealth prescribing
• Georgia: In-person exam required prior to prescribing weight loss medications (though new 2024 legislation expanded NP/PA prescribing authority)
• Mississippi: State guidelines require an initial in-person evaluation for weight management therapy
• New Jersey: Comprehensive in-person exam, including lab work and psychological screening, required at start of treatment
• North Dakota: Hands-on initial evaluation expected for weight-loss treatment per state medical board guidance
• South Carolina: First patient visit must be in-person; subsequent follow-ups may be virtual
• Texas: Standard of care typically requires initial in-person exam, though not explicitly mandated by statute
• Virginia: Requires initial physical exam, laboratory testing, and documented diet/exercise plan before prescribing

What This Means: If you live in one of these states, your telehealth provider may require you to visit a local clinic or partner facility for your first appointment. After that initial visit, ongoing care can usually continue virtually.

States With Additional Treatment Requirements

Beyond the in-person visit question, some states have specific protocols for weight loss medication management:

Florida:

• Patients must have a BMI ≥30 (or ≥27 with comorbidities)
• Follow-up visits required at least every 3 months during treatment
• Treatment plan must include lifestyle modifications

Connecticut:

• Must include behavioral counseling component
• Diet and exercise plan required as part of treatment

Virginia:

• Comprehensive initial work-up (physical exam, labs, personalized diet/exercise plan)
• 30-day follow-up mandatory after starting medication
• Detailed documentation of risks and informed consent required

States With Minimal Restrictions

Many states have embraced telehealth for weight management with few special requirements beyond standard medical practice:

Fully Telehealth-Friendly (No In-Person Mandate):

• California
• Connecticut (with counseling requirement)
• Illinois
• New York
• Pennsylvania
• Utah
• Washington

In these states, a thorough virtual consultation—including medical history, current weight and height verification, discussion of risks and benefits—is sufficient to establish care and prescribe medication.

Who Can Prescribe Weight Loss Medications Via Telehealth?

Physician Prescribing (MD/DO)

All states allow licensed Medical Doctors (MDs) and Doctors of Osteopathic Medicine (DOs) to prescribe GLP-1 weight loss medications via telehealth, provided they’re licensed in the state where the patient is physically located during the consultation.

Nurse Practitioner and Physician Assistant Authority

The landscape for Advanced Practice Providers (APPs)—Nurse Practitioners (NPs) and Physician Assistants (PAs)—varies significantly by state:

Full Independent Practice (NPs Can Prescribe Without Physician Oversight):

• California (after 3+ years experience)
• Connecticut (after 3 years collaboration)
• Delaware (after 2 years collaboration)
• New York (after 3,600 hours supervised practice)
• North Dakota
• Utah
• Virginia (after 2 years collaboration)
• Washington
• Plus 25+ other states

Collaborative Practice (Physician Agreement/Protocol Required):

• Arkansas
• Florida (limited independence in primary care only)
• Georgia (now includes Schedule II authority with delegation)
• Illinois
• Mississippi
• Pennsylvania
• South Carolina
• Texas (strict physician oversight requirements)

What This Means for Patients: You may see an NP or PA for your telehealth weight loss consultation—this is completely legal and often preferred, as many NPs specialize in obesity medicine. Klarity Health ensures all providers are appropriately credentialed and practice within their state’s scope of practice laws.

The Three Main Weight Loss Medications Available Via Telehealth

Wegovy (Semaglutide 2.4mg)

FDA Status: Approved specifically for chronic weight management (June 2021)

Eligibility:

• BMI ≥30, or
• BMI ≥27 with weight-related comorbidity (type 2 diabetes, hypertension, high cholesterol)

Key Points:

• Once-weekly self-injection
• Typically prescribed with 30-day supply initially, up to 90 days once stable
• Requires lifestyle modification (diet and exercise) as part of treatment plan
• No compounding allowed: FDA banned compounded semaglutide for weight loss in May 2025

Common Side Effects: Nausea, diarrhea, constipation, vomiting (usually mild and temporary)

Ozempic (Semaglutide 0.5–1mg)

FDA Status: Approved for type 2 diabetes; used off-label for weight loss

Eligibility:

• Primarily for patients with type 2 diabetes
• Sometimes prescribed off-label for weight management when Wegovy is unavailable or insurance doesn’t cover it

Key Points:

• Same active ingredient as Wegovy, lower doses
• Off-label use requires clear documentation and informed consent
• Should not be combined with Wegovy (same medication)
• Typically 30-day supply prescriptions

Mounjaro (Tirzepatide) / Zepbound

FDA Status: Mounjaro approved for type 2 diabetes; Zepbound (higher dose tirzepatide) approved for weight management (late 2023)

Eligibility: Same BMI criteria as Wegovy

Key Points:

• Dual-action GLP-1/GIP receptor agonist
• Often more effective for weight loss than semaglutide alone
• Once-weekly injection
• Dispensed in monthly ‘titration packs’ that gradually increase dosage
• Requires patient training on self-injection technique

How Telehealth Weight Loss Programs Work: What to Expect

Step 1: Comprehensive Medical Evaluation

Legitimate telehealth providers will require:

Medical History Review:

• Current and past medical conditions
• Medications and supplements
• Allergies
• Previous weight loss attempts
• Family history (especially thyroid cancer or MEN2 syndrome)

Current Health Assessment:

• Height and weight verification (often with photo documentation)
• BMI calculation
• Blood pressure (if available)
• Recent lab results (some providers may require recent metabolic panel)

Psychological Screening:

• History of eating disorders
• Depression or anxiety (important for medication safety)
• Realistic expectations about weight loss timeline

Step 2: Live Video Consultation

You’ll meet via secure video platform with a licensed provider (MD, DO, NP, or PA) who will:

• Review your medical history and eligibility
• Discuss treatment options and which medication might be best
• Explain potential side effects and how to manage them
• Review contraindications (conditions that would make GLP-1 therapy unsafe)
• Create a personalized treatment plan including diet and exercise goals
• Obtain informed consent
• Answer all your questions

Red Flag: Be wary of any service that prescribes without a live video consultation or thorough medical review.

Step 3: Prescription and Pharmacy

If approved, your provider will send an electronic prescription to:

• Your preferred local pharmacy, or
• A partner mail-order pharmacy (often more convenient for specialty medications)

Important: These medications are not available over-the-counter or from international pharmacies. All prescriptions must come from a U.S.-licensed pharmacy.

Step 4: Medication Training and Support

Before your first injection, you’ll receive:

• Detailed injection technique instructions (video demonstrations)
• Proper storage guidance (refrigeration required)
• Dosage escalation schedule (GLP-1s start low and gradually increase)
• Side effect management strategies
• 24/7 clinical support contact information

Step 5: Ongoing Monitoring and Follow-Up

Regular check-ins are medically necessary and often legally required:

First Month:

• Follow-up within 2-4 weeks to assess tolerance
• Side effect check
• Early weight loss tracking

Ongoing:

• Video visits every 1-3 months (depending on state requirements)
• Dose adjustments as needed
• Lab monitoring (typically every 3-6 months)
• Treatment plan modifications

State-Specific Requirements:

• Florida: Minimum every 3 months
• Virginia: Required 30-day follow-up after starting
• Most states: Provider discretion, but monthly or quarterly recommended

Who Qualifies for Telehealth Weight Loss Medication?

Clinical Eligibility Criteria

To receive GLP-1 weight loss medications, you typically must meet:

BMI Requirements:

• BMI ≥30: Qualifies for weight loss medication
• BMI 27-29.9: May qualify if you have weight-related health conditions like:
• Type 2 diabetes or prediabetes
• High blood pressure
• High cholesterol
• Sleep apnea
• Cardiovascular disease

Additional Factors:

• Age 18+ (some providers treat adolescents 12+ with parental consent)
• Documented attempts at lifestyle modification
• Commitment to dietary changes and physical activity
• No contraindications (see below)

Who Should NOT Take GLP-1 Medications

Absolute Contraindications (disqualifying conditions):

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Pregnancy or planning to become pregnant (must stop 2 months before attempting conception)
• Breastfeeding
• History of severe allergic reaction to semaglutide or tirzepatide
• Active pancreatitis or history of severe pancreatitis

Relative Contraindications (require careful evaluation):

• Active gallbladder disease or history of gallstones
• Severe gastroparesis or gastrointestinal disorders
• History of eating disorders (bulimia, anorexia)
• Diabetic retinopathy (may worsen with rapid weight loss)
• Kidney disease (dose adjustments may be needed)
• Severe depression or suicidal ideation

Medication Interactions:

• Other GLP-1 medications (never combine)
• Insulin (requires dose adjustment)
• Sulfonylureas (increased low blood sugar risk)
• Warfarin (may affect blood clotting)

Reputable telehealth providers screen for all these conditions during your initial evaluation.

Common Misconceptions About Telehealth Weight Loss Treatment

Myth 1: ‘Anyone can get Ozempic online with a quick questionnaire’

Reality: Legitimate providers conduct thorough medical evaluations. If you don’t meet clinical criteria (BMI requirements, appropriate health profile), responsible providers will recommend lifestyle modifications or other options instead.

Myth 2: ‘Telehealth weight loss is just about getting a prescription’

Reality: Effective programs include:

• Comprehensive medical oversight
• Nutrition counseling
• Exercise planning
• Behavioral support
• Regular monitoring

Medication is one tool in a comprehensive weight management approach.

Myth 3: ‘It’s cheaper to buy compounded semaglutide online’

Reality: As of May 2025, the FDA banned most compounded semaglutide products for weight loss. Using non-FDA-approved or international versions carries serious risks:

• Unknown purity and concentration
• Potential contamination
• No safety guarantees
• Possible legal issues

Stick with FDA-approved medications from licensed U.S. pharmacies.

Myth 4: ‘Once I start, I can manage it myself without follow-ups’

Reality: These are powerful medications requiring ongoing medical supervision:

• Dose adjustments based on response and tolerance
• Side effect management
• Lab monitoring for potential complications
• Evaluation of continued appropriateness

Skipping follow-ups increases risks and reduces effectiveness.

Safety Considerations and Red Flags

How to Identify Legitimate Telehealth Providers

Green Flags (signs of quality care):

✅ Licensed providers clearly identified by name, credentials, and state license numbers
✅ Thorough medical intake including detailed questionnaire and document upload
✅ Live video consultation required (not just messaging or forms)
✅ Transparent pricing with clear breakdown of consultation, medication, and follow-up costs
✅ Regular follow-up schedule built into the program
✅ Accepts insurance or offers cash-pay options with competitive pricing
✅ Clear explanation of risks, benefits, and alternatives
✅ Access to clinical support team for questions between visits
✅ Prescriptions sent to licensed U.S. pharmacies only

Red Flags (warning signs to avoid):

🚩 Guaranteed prescription without proper evaluation
🚩 No live provider consultation (automated prescribing)
🚩 Offering compounded or ‘generic’ semaglutide from unlicensed sources
🚩 International or ‘Canadian pharmacy’ partners
🚩 Unclear provider credentials or unlicensed staff
🚩 No follow-up care or monitoring plan
🚩 Pressure to pay upfront for months of treatment before evaluation
🚩 Claims of ‘miracle results’ or unrealistic promises
🚩 Waiving medical contraindications or not screening properly

Privacy and Data Security

Under HIPAA (federal health privacy law), telehealth providers must:

• Use secure, encrypted video platforms
• Protect your medical records
• Limit sharing of your health information

Some states have additional privacy protections:

• Washington’s My Health My Data Act (2023): Extra safeguards for sensitive health data, including weight and body image information
• California Consumer Privacy Act (CCPA): Additional rights to control your personal information

What to ask your provider:

• How is my video consultation secured?
• Where are my medical records stored?
• Who has access to my information?
• Do you sell health data to third parties? (Should be NO)

Cost Considerations: Insurance vs. Cash Pay

Insurance Coverage

GLP-1 medications for weight loss have limited insurance coverage:

Wegovy/Zepbound (FDA-approved for obesity):

• Some commercial insurance plans cover with prior authorization
• Medicare does not cover weight loss medications (by law)
• Medicaid coverage varies by state (about 15 states cover as of 2025)

Ozempic/Mounjaro (diabetes medications):

• Usually covered when prescribed for type 2 diabetes
• Off-label use for weight loss typically not covered
• Prior authorization often required

Cost Without Insurance:

• Wegovy: $1,300-$1,500/month retail
• Ozempic: $900-$1,000/month retail
• Mounjaro/Zepbound: $1,000-$1,200/month retail

Telehealth Program Costs

Many telehealth weight loss programs offer all-inclusive pricing:

Typical Cash-Pay Programs:

• Initial consultation: $49-$99
• Monthly medication + care: $200-$400 (includes provider visits, medication, support)
• Some programs offer manufacturer coupons or savings cards

What Klarity Health Offers:

• Accept both insurance and cash pay (flexibility based on your coverage)
• Transparent pricing with no hidden fees
• Licensed provider availability across multiple states
• Comprehensive care including nutrition guidance and ongoing support

Cost Comparison: For many patients, all-inclusive telehealth programs are more affordable than traditional care even with insurance, especially when considering:

• No separate copays for multiple office visits
• No travel time or costs
• Streamlined prescription management
• Built-in support services

Klarity Health’s Approach to Telehealth Weight Management

At Klarity Health, we’ve built our weight loss program around three core principles: medical safety, accessibility, and personalized care.

Comprehensive Medical Oversight

Every patient works with a licensed healthcare provider (MD, DO, or NP) who specializes in obesity medicine and metabolic health. Our process includes:

• Thorough initial evaluation assessing your complete medical history, current health status, and weight loss goals
• Evidence-based treatment plans aligned with the latest clinical guidelines
• Regular follow-up visits to monitor progress, adjust medications, and address concerns
• 24/7 clinical support via secure messaging for questions between appointments

Nationwide Availability

Klarity Health providers are licensed across multiple states, making it easy to access care whether you live in California, Texas, Florida, or anywhere in between. We stay current with each state’s specific requirements—if your state mandates an initial in-person exam, we’ll help coordinate that seamlessly.

Flexible Payment Options

We understand that cost is a real barrier to weight loss treatment. That’s why we:

• Accept insurance (we’ll check your coverage and handle prior authorizations)
• Offer transparent cash-pay pricing if insurance doesn’t cover or you prefer to pay out-of-pocket
• Help you access manufacturer savings programs to reduce medication costs
• Never surprise you with hidden fees

Beyond the Prescription

Medication is just one part of sustainable weight loss. Klarity’s program includes:

• Personalized nutrition guidance from registered dietitians
• Exercise recommendations tailored to your fitness level and goals
• Behavioral coaching to address emotional eating and build lasting habits
• Community support through online groups and educational resources
• Holistic health focus addressing sleep, stress, and overall wellness

Looking Ahead: The Future of Telehealth Weight Loss Treatment

Regulatory Outlook for 2026 and Beyond

The telehealth landscape continues to evolve, with strong momentum toward expanded access:

Federal Level:

• The TREATS Act (reintroduced October 2025) would make certain telehealth prescribing flexibilities permanent
• DEA is expected to announce a 4th extension of telehealth rules or publish new permanent regulations
• Bipartisan support suggests telehealth access will continue and likely expand

State Level:

• More states moving toward full practice authority for Nurse Practitioners (enabling more provider availability)
• Interstate licensure compacts making it easier for providers to see patients across state lines
• Trend toward harmonizing telehealth standards to reduce confusion

What This Means for Patients: Access to telehealth weight loss treatment will likely become easier and more standardized over the next few years.

Emerging Medications and Treatment Options

The weight loss medication landscape is rapidly expanding:

New FDA Approvals Expected:

• Oral GLP-1 medications (moving beyond injections)
• Triple-action drugs combining GLP-1, GIP, and glucagon
• Medications targeting different weight loss mechanisms

Combination Therapies:

• Research on combining GLP-1s with other metabolic medications
• Precision medicine approaches based on genetic factors

Telehealth will play a crucial role in bringing these innovations to patients across the country.

Frequently Asked Questions

Q: Do I need to live in the same state as my provider?
A: Yes. For telehealth, your provider must be licensed in the state where you’re physically located during the consultation. This is required by state medical practice laws. Klarity Health has providers licensed in multiple states to serve patients nationwide.

Q: Can I switch from in-person care to telehealth for ongoing treatment?
A: Absolutely. If you’re already taking a GLP-1 medication, you can transition to telehealth for continued management. Your new provider will review your current treatment and medical records to ensure continuity of care.

Q: What if I travel or move to another state while on treatment?
A: If you move permanently, you’ll need to establish care with a provider licensed in your new state. For temporary travel, most providers can accommodate you if it’s a short trip, but state rules vary. Let your provider know in advance if you’ll be out of state.

Q: Is telehealth as effective as in-person care for weight loss?
A: Research shows telehealth weight management programs achieve comparable outcomes to in-person care when they include comprehensive medical oversight, regular follow-up, and lifestyle support. The convenience factor often leads to better adherence and long-term success.

Q: How quickly can I get started?
A: With telehealth, you can often have your initial consultation within 24-48 hours of signing up, depending on provider availability. If approved, your prescription can be sent to the pharmacy same-day, with medication typically available within a few days.

Q: What happens if I have side effects?
A: GLP-1 medications are generally well-tolerated, but side effects (mainly gastrointestinal) do occur, especially when starting or increasing dose. Your telehealth provider will:

• Give you strategies to minimize side effects
• Adjust your dose if needed
• Be available via secure messaging for questions
• Schedule an urgent visit if you have concerning symptoms

Most side effects are mild and temporary, resolving within a few weeks.

Q: Can men get telehealth weight loss medication too?
A: Yes! While GLP-1 medications are often marketed to women, they’re equally effective for men. Clinical studies included both sexes, and men often see excellent results. Klarity’s providers treat patients of all genders.

Q: Will I need blood work?
A: Many providers require recent lab results (typically within the past 6 months) before starting treatment, including:

• Comprehensive metabolic panel (kidney and liver function)
• Lipid panel (cholesterol)
• Hemoglobin A1C (blood sugar)
• Thyroid function

Your provider will tell you which labs are needed. Some states (like New Jersey and Virginia) legally require initial lab work. Ongoing monitoring typically includes labs every 3-6 months.

Q: What if I’m already taking other medications?
A: Your provider will review all your current medications for potential interactions. GLP-1s are generally safe to combine with most medications, but some require special attention:

• Diabetes medications: May need dose adjustments to avoid low blood sugar
• Blood thinners: Absorption could be affected; monitoring needed
• Thyroid medication: Timing of doses might need adjustment

Always disclose all medications, supplements, and over-the-counter drugs during your evaluation.

Take the Next Step Toward Your Weight Loss Goals

Telehealth has made effective, medically supervised weight loss more accessible than ever. With GLP-1 medications like Wegovy, Ozempic, and Mounjaro proving highly effective for long-term weight management, there’s never been a better time to explore your options.

If you’re ready to start your weight loss journey:

✅ Verify you meet the basic criteria: BMI ≥30 or ≥27 with health complications
✅ Check your state’s requirements using our comprehensive table above
✅ Choose a legitimate telehealth provider that offers comprehensive medical care, not just prescriptions
✅ Schedule your consultation with a licensed provider who can create a personalized plan
✅ Commit to the full program including lifestyle changes and regular follow-ups

Klarity Health makes it simple: Our providers are available to see you virtually, accept both insurance and cash pay, and offer transparent pricing with no hidden costs. We’ll help you determine if telehealth weight loss medication is right for you and support you every step of the way.

Ready to get started? Visit Klarity Health today to schedule your confidential consultation with a weight loss specialist. Take control of your health from the comfort of your home—with the medical expertise and ongoing support you deserve.

Citations & Sources

1. U.S. Drug Enforcement Administration (DEA) – ‘DEA and HHS Extend Telemedicine Flexibilities through 2025’ (November 15, 2024). Official announcement confirming extension of pandemic-era telehealth rules through December 31, 2025. www.dea.gov

2. Axios News – ‘COVID-era telehealth prescribing extended for Adderall and more’ (November 18, 2024). News analysis of DEA’s third extension of telehealth flexibilities for controlled substance prescribing. www.axios.com

3. McDermott Will & Emery LLP – ‘DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025’ (November 18, 2024). Legal analysis of federal telehealth regulations and Ryan Haight Act implications. www.mwe.com

4. Goodwin Procter LLP – ‘The Changing Regulatory and Reimbursement Landscape for Anti-Obesity Medications’ (March 27, 2024). Comprehensive legal alert detailing state-specific prescribing requirements for weight loss medications in Florida, New Jersey, and Virginia. www.goodwinlaw.com

5. Reuters – ‘Hims to cut 4% of workforce amid ban on weight-loss drug copies’ (May 30, 2025). News report on FDA’s enforcement action ending routine compounding of semaglutide for weight loss. www.reuters.com

This article was last updated December 17, 2025. Telehealth regulations and medication availability are subject to change. Always consult with a licensed healthcare provider for personalized medical advice.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid